Publication
Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment
dc.contributor.author | Ma, Jingyi | |
dc.contributor.author | Moussawi, Khatoun Al | |
dc.contributor.author | Lou, Hantao | |
dc.contributor.author | Chan, Hok Fung | |
dc.contributor.author | Wang, Yihua | |
dc.contributor.author | Chadwick, Joseph | |
dc.contributor.author | Phetsouphanh, Chansavath | |
dc.contributor.author | Slee, Elizabeth A. | |
dc.contributor.author | Zhong, Shan | |
dc.contributor.author | Leissing, Thomas M. | |
dc.contributor.author | Roth, Andrew | |
dc.contributor.author | Qin, Xiao | |
dc.contributor.author | Chen, Shuo | |
dc.contributor.author | Yin, Jie | |
dc.contributor.author | Ratnayaka, Indrika | |
dc.contributor.author | Hu, Yang | |
dc.contributor.author | Louphrasitthiphol, Pakavarin | |
dc.contributor.author | Taylor, Lewis | |
dc.contributor.author | Bettencourt, Paulo J. G. | |
dc.contributor.author | Muers, Mary | |
dc.contributor.author | Greaves, David R. | |
dc.contributor.author | McShane, Helen | |
dc.contributor.author | Goldin, Robert | |
dc.contributor.author | Soilleux, Elizabeth J. | |
dc.contributor.author | Coleman, Mathew L. | |
dc.contributor.author | Ratcliffe, Peter J. | |
dc.contributor.author | Lu, Xin | |
dc.date.accessioned | 2024-03-06T12:16:13Z | |
dc.date.available | 2024-03-06T12:16:13Z | |
dc.date.issued | 2024-02-29 | |
dc.description.abstract | Hypoxia signaling influences tumor development through both cell-intrinsic and -extrinsic pathways. Inhibiting hypoxia-inducible factor (HIF) function has recently been approved as a cancer treatment strategy. Hence, it is important to understand how regulators of HIF may affect tumor growth under physiological conditions. Here we report that in aging mice factor-inhibiting HIF (FIH), one of the most studied negative regulators of HIF, is a haploinsufficient suppressor of spontaneous B cell lymphomas, particular pulmonary B cell lymphomas. FIH deficiency alters immune composition in aged mice and creates a tumor-supportive immune environment demonstrated in syngeneic mouse tumor models. Mechanistically, FIH-defective myeloid cells acquire tumor-supportive properties in response to signals secreted by cancer cells or produced in the tumor microenvironment with enhanced arginase expression and cytokine-directed migration. Together, these data demonstrate that under physiological conditions, FIH plays a key role in maintaining immune homeostasis and can suppress tumorigenesis through a cell-extrinsic pathway. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.1073/pnas.2309957121 | pt_PT |
dc.identifier.eid | 85186308201 | |
dc.identifier.issn | 0027-8424 | |
dc.identifier.pmid | 38422022 | |
dc.identifier.uri | http://hdl.handle.net/10400.14/44141 | |
dc.identifier.wos | 001207786500003 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Tumor microenvironment | pt_PT |
dc.subject | Hypoxia-inducible factor | pt_PT |
dc.subject | Factor-inhibiting HIF | pt_PT |
dc.subject | B cell lymphoma | pt_PT |
dc.subject | Tumor suppression | pt_PT |
dc.title | Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.issue | 10 | pt_PT |
oaire.citation.title | Proceedings of the National Academy of Sciences of the United States of America | pt_PT |
oaire.citation.volume | 121 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |